Investor Relations

Corporate Profile

Focusing on PCR,NGS,ELISA and lateral flow rapid test kits including food safety test kits, human and animal infectious disease diagnostic kits in US for 12 years.

REAGEN manufactures innovative diagnostic kits for detection of antibiotics, veterinary drugs, mycotoxins, algal toxins, estrogens, pesticides, industrial pollutants, infectious diseases, as well as raw materials for molecular diagnostics and immunoassays. Our diagnostic systems are fast and easy to operate and designed to efficiently guarantee the quality of the assays in the laboratory. 

Past Events

REAGEN recently participated in activities.

IAFP

Each year the International Association for Food Protection (IAFP) holds an Annual Conference to provide attendees with relevant information on current and emerging food safety issues, the latest science, and innovative solutions to new and recurring problems.

MEDICA

REAGEN brings IVD product testing solutions to communicate and learn from exhibiting professionals from all over the world at MEDICA.

REAGEN INVESTORS

The following is a list of REAGEN investors’ shareholding ratios:

REAGEN Team

1%

Max Deng Trust

50%

Pasaca Capital

30%

INNOVA Medical Group

15%

Leo Cao

1%

Cindy

1%

Gump Deng

1%

Zhimin Liu

1%

REAGEN Team

1%